All anti Tnf blockers significantly controlled signs and symptoms of psoriatic arthritis and ameliorated the quality of life of patients
Comparison of efficacy and safety of infliximab (INF), etanercept (ETN) and adalimumab (ADA) in psoriatic arthritis patients who experienced an inadequate response to previous disease modifying antirheumatic drugs / Scarpa, Raffaele; Atteno, M; Costa, L; Peluso, Rosario; Lofrano, M; Iervolino, S; Caso, F; Spano, A; Manguso, F; DEL PUENTE, Antonio. - In: RHEUMATOLOGY. - ISSN 1462-0324. - STAMPA. - 47:(2008), pp. 68-68.
Comparison of efficacy and safety of infliximab (INF), etanercept (ETN) and adalimumab (ADA) in psoriatic arthritis patients who experienced an inadequate response to previous disease modifying antirheumatic drugs
SCARPA, RAFFAELE;PELUSO, ROSARIO;DEL PUENTE, ANTONIO
2008
Abstract
All anti Tnf blockers significantly controlled signs and symptoms of psoriatic arthritis and ameliorated the quality of life of patientsFile in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
